Opendata, web and dolomites
H2020 projects about "mucosal"
The page lists 50 projects related to the topic "mucosal".
| # | |||
|---|---|---|---|
| 1 | SAPHIR | Strengthening Animal Production and Health through the Immune Response | 2015 |
| 2 | EMI-TB | Eliciting Mucosal Immunity to Tuberculosis | 2015 |
| 3 | GLYCO-TOOLS | Bio-Inspired Tools for Glycoscience | 2015 |
| 4 | GutILC3 | Cell-cell interactions critical to ILC3 function in the human gut | 2015 |
| 5 | DCmucoHIV | HIV/SIV exploits DCs in mucosal infection: mechanisms of transmission and modulation by semen associated factors | 2015 |
| 6 | ImmunoFarm | IgA-based oral therapy for protection of piglets against infection with enterotoxigenic E. coli. | 2015 |
| 7 | MUCDIFF | Competition between the enteric pathogen Clostridium difficile and the commensal members of the gut microbiota for mucosal sugars | 2015 |
| 8 | LABVaccFish | USE OF LACTIC ACID BACTERIA AS DELIVERY VEHICLE FOR ORAL VACCINATION OF FISH | 2016 |
| 9 | GliaInnateSensing | Glia-derived factors in innate lymphoid cell sensing and intestinal defence | 2015 |
| 10 | IMMUNOBIOME | Identifying microbiotal triggers of inflammatory bowel disease through the lens of the immune system | 2016 |
| 11 | MucoVac | Unravelling the mode of action of mucosal adjuvants | 2016 |
| 12 | MAIT | Evolutionary conserved T cells specific for a microbial metabolite: deciphering their development in the thymus and mapping their interactions with the gut microbiota in vivo. | 2016 |
| 13 | ZF-ILC | Characterization of zebrafish innate lymphoid cells and IL-22 | 2017 |
| 14 | GutBCells | Cellular Dynamics of Intestinal Antibody-Mediated Immune Response | 2016 |
| 15 | INVADIS | Microbial invasion and dissemination within the host, mechanisms and effects | 2016 |
| 16 | CrUCCial | Novel diagnostic and therapeutic approach to inflammatory bowel disease based on functional characterization of patients: the CrUCCial index | 2016 |
| 17 | ILC_REACTIVITY | Biological Determinants of ILC Reactivity for Immune Responses in Health and Disease | 2016 |
| 18 | MUC2GO | THE ROLE OF MUCINS AND MUCUS IN THE DISEASES CYSTIC FIBROSIS, CELIAC DISEASE, AND ULCERATIVE COLITIS | 2016 |
| 19 | MILEAGE | Microelements in Life Expectancy and Aging | 2017 |
| 20 | NEOFIBRIN | Advanced material for the regeneration of oral mucosa injuries | 2017 |
| 21 | FungArth | Role of intestinal fungal communities in arthritic pathology | 2017 |
| 22 | TracVac | Developing a Chlamydia Trachomatis vaccine | 2017 |
| 23 | MIRA | Characterizing Microbe-specific Immune Responses in the pathogenesis of Autoimmunity | 2017 |
| 24 | FusionPAMPs | New generation of chimeric TLR2-NOD agonist compounds for vaccine adjuvants | 2017 |
| 25 | IMMUNO_CRC | Microbiota-immune interaction in colorectal cancer | 2017 |
| 26 | Glyco-Platforms | Novel smart glyco-nanomaterials as targeted therapeutics. | 2017 |
| 27 | PolyVac | Polysaccharide-based membrane for sublingual vaccination | 2017 |
| 28 | TEMUBLYM | Teleost mucosal B1-like lymphocytes at the crossroad of tolerance and immunity | 2017 |
| 29 | INIMUD | Impact of Neuromedin U in type 2 immunity and mucosal defence | 2017 |
| 30 | ALLERGUT | Mucosal Tolerance and Allergic Predisposition: Does it all start in the gut? | 2017 |
| 31 | TissueLymphoContexts | Tissue-resident Lymphocytes: Development and Function in “real-life” Contexts | 2018 |
| 32 | MASTFAST | Rapid production of HUMAN MAST CELLS | 2017 |
| 33 | Glyco-DeCon | Decontamination by glycosylation based wipes | 2018 |
| 34 | TOPNIN | Tracing of pulmonary neuro-immune networks | 2018 |
| 35 | cureCD | Function of long non-coding RNA in Crohn Disease Ulcer Pathogenesis | 2018 |
| 36 | PREVENT RA | Towards prevention of autoimmune diseases: the case of rheumatoid arthritis | 2018 |
| 37 | ONCOTICS | Probiotics for the Oncological Patients | 2018 |
| 38 | MicroTher | MicroTher: Drug Discovery from the Microbiota | 2018 |
| 39 | DaPhNIs | Role of the Maternal Gut Microbiota in Immune Activation at the Maternal-Foetal Interface: Impact on Preeclampsia and Offspring's Immune Development | 2019 |
| 40 | ENTRI | Enteric-nervous-system-mediated regulation of intestinal inflammation | 2019 |
| 41 | CLEAN | Well-Confined Mucosal LasEr Ablation with a Negative Pressure Based Endoscopy Capsule | 2019 |
| 42 | BioNanoProbes | Bio-Inspired Glycan-NanoProbes as Antimicrobial Pro-Drugs | 2019 |
| 43 | SHIGETECVAX | Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea | 2019 |
| 44 | RIVELIN-CLO | The Ultimate Therapy for the Oral Lichen Planus | 2019 |
| 45 | CeleSte | Commensal microbiota regulation of neuro-immune networks | 2020 |
| 46 | PI3K-in-tolerance | PI3K delta role in dendritic cell antigen processing and presentation to control gut tolerance | 2019 |
| 47 | Bac2MUC | Bacteria-mucin interactions – Shaping intestinal epithelial responses in health and disease | 2020 |
| 48 | GUT-SEQ | Single-cell analysis of intestinal lymphocytes reveals targets for treatment of inflammatory bowel disease | 2020 |
| 49 | REpAIR | Spatio-Temporal Regulation of Inflammation and Tissue Regeneration: Studying the immune system - tissue - microbiota communication to develop targeted therapies for immune-mediated diseases and cancer | 2020 |
| 50 | GUTMAPS | Cellular cartography of the intestine in health and inflammation | 2021 |